Leo Brokerage, LLC Amgen Inc Transaction History

Leo Brokerage, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $60,285 - $73,478	-267 Reduced 19.5%	1,102 $266,000
Q2 2022 Jul 11, 2022	SELL	$230.71 - $256.74 $402,358 - $447,754	-1,744 Reduced 56.02%	1,369 $333,000
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $682,587 - $755,120	3,113 New	3,113 $753,000
Q3 2021 Oct 13, 2021	SELL	$212.27 - $248.7 $244,110 - $286,005	-1,150 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$233.58 - $259.14 $4,905 - $5,441	21 Added 1.86%	1,150 $280,000
Q1 2021 Apr 13, 2021	BUY	$221.91 - $258.6 $3,328 - $3,879	15 Added 1.35%	1,129 $281,000
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $28,129 - $33,497	-130 Reduced 10.45%	1,114 $256,000
Q3 2020 Nov 06, 2020	BUY	$234.65 - $260.95 $291,904 - $324,621	1,244 New	1,244 $293,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Leo Brokerage, LLC, based on Form 13F filings with the SEC.

Stay updated on Leo Brokerage, LLC with notifications on news.